BlackRock’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15
| Closed | -$98 | – | 5274 |
|
|
2023
Q4 | $98 | Hold |
15
| – | – | ﹤0.01% | 5256 |
|
|
2023
Q3 | $73 | Hold |
15
| – | – | ﹤0.01% | 5333 |
|
|
2023
Q2 | $146 | Sell |
15
-1,455
| -99% | -$14.2K | ﹤0.01% | 5369 |
|
|
2023
Q1 | $14.7K | Buy |
1,470
+47
| +3% | +$470 | ﹤0.01% | 5201 |
|
|
2022
Q4 | $31.3K | Buy |
1,423
+31
| +2% | +$682 | ﹤0.01% | 5232 |
|
|
2022
Q3 | $63K | Sell |
1,392
-39
| -3% | -$1.77K | ﹤0.01% | 5216 |
|
|
2022
Q2 | $81K | Sell |
1,431
-23
| -2% | -$1.3K | ﹤0.01% | 5204 |
|
|
2022
Q1 | $87K | Sell |
1,454
-71
| -5% | -$4.25K | ﹤0.01% | 5221 |
|
|
2021
Q4 | $149K | Buy |
1,525
+174
| +13% | +$17K | ﹤0.01% | 5096 |
|
|
2021
Q3 | $232K | Sell |
1,351
-29
| -2% | -$4.98K | ﹤0.01% | 4883 |
|
|
2021
Q2 | $226K | Buy |
+1,380
| New | +$226K | ﹤0.01% | 4807 |
|